Caris Life Sciences (CAI) Change in Cash (2024 - 2026)

Caris Life Sciences' Change in Cash history runs 3 years deep, the most recent figure standing at $23.3 million for Q1 2026.

• In Q1 2026, Change in Cash rose 171.32% year-over-year to $23.3 million; the TTM figure through Mar 2026 stood at $788.1 million (changed N/A YoY), while the FY2025 annual figure was $732.0 million, up 9026.22% from the prior year.
• Change in Cash for Q1 2026 stood at $23.3 million, down from $43.1 million in the prior quarter.
• The five-year high for Change in Cash was $687.4 million in Q2 2025, with the low at -$71.2 million in Q3 2024.
• The 3-year median for Change in Cash is $23.3 million (2026), against an average of $91.9 million.
• Peak annual rise in Change in Cash reached 205.06% in 2025, while the deepest fall reached 148.18% in 2025.
• Caris Life Sciences' Change in Cash stood at -$41.0 million in 2024, then soared by 205.06% to $43.1 million in 2025, then sank by 45.78% to $23.3 million in 2026.
• Business Quant data shows CAI's Change in Cash at $23.3 million in Q1 2026, $43.1 million in Q4 2025, and $34.3 million in Q3 2025.